Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
April 6, 2021
Patent Application Number
16606817
Date Filed
May 14, 2018
Patent Primary Examiner
Patent abstract
The application relates to phenyl- or naphthylsulfonamide derivatives of the structural formula (I). The compounds are described as inhibitors of USP30 (ubiquitin specific peptidase 30) useful for the treatment of conditions involving mitochondrial defects including neurodegenerative diseases such as Alzheimer's and Parkinson's or a neoplastic disease such as leukemia.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
